Inspiration has no religion, its for every one!

Main menu

Dr. Reddy’s wonder drug for diabetes!

Dr. Reddy’s labs (DRL) has been working hard on its vision to move beyond Generic.Balaglitazone is result of this vision.Positive test results indicate a move in the right direction.If things fall in place DRL is looking at a revenue stream of 2 – 3 billion in the 1st 5 years of launch.Currently the Anti Diabetic market is stagnated with old molecules. Patients have to some extent become immune or respond less to the current drugs on offer a new drug us always welcomed.